The number of patients required to give a statistically significant result depends on the question the trial wants to answer. For example, to show the effectiveness of a new drug in a non-curable disease as metastatic kidney cancer requires many fewer patients than in a highly curable disease as seminoma if the drug is compared to a placebo.
The company's lead product candidate is currently in last-stage development as a renal cell cancer treatment.
John Baron MP recently met with nurses, clinicians and patient representatives at an event in the House of Lords on 'Improving Outcomes for Kidney Cancer Patients'.
Doctors will today unveil the world's first sticking plaster that can cure cancer.
By observing a laparoscopic radiofrequency ablation procedure live, and seeing first hand the benefits to patients, Sarasota Memorial Urologist Robert Carey, MD, hopes more surgeons will embrace less invasive cancer treatments.
China's demand for Kidney Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow.
Hypoxia-inducible factor (HIF) plays an important role in renal tumourigenesis. In the majority of clear cell RCC (ccRCC), the most frequent and highly vascularized RCC subtype, HIF is constitutively activated by inactivation of the von Hippel-Lindau gene.
According to a new study, men employed in occupations with potential exposure to high levels of sunlight have a reduced risk of kidney cancer compared with men who were less likely to be exposed to sunlight at work. The study did not find an association between occupational sunlight exposure and kidney cancer risk in women. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study is the largest case-control study of kidney cancer to investigate the association with occupational sunlight exposure.
Abstracts: Renal Cell Cancer. Complete information is available on this website: http://www.gucasymposium.org.